Ascendis Pharma A/S Insider Trades
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 9 · $777.07K
- Sales
- 3 · $5.51M
- Shares bought / sold
- 3.25K / 22.70K
- Net activity
- Net selling $4.7 million
Ascendis Pharma A/S insider activity
Over the last 12 months, Ascendis Pharma A/S insiders reported 13 transactions on SEC Form 4: 9 open-market purchases and 3 sales. Insiders bought $777,067 and sold $5.5 million worth of stock, for net insider selling of $4.7 million. The largest seller was JENSEN FLEMMING STEEN, with $4.6 million in reported sales.
The most recent filing shows Bodenhoff Mads (SVP & PAO) reporting a transaction in 3,000 shares at $110.00 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ASND's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ASND insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Bodenhoff MadsSVP & PAO | Sale | 3,000 | $810.57K | Form 4 |
| Sep 8, 2026 | Bodenhoff MadsSVP & PAO | Option exercise | 3,000 | $330.00K | Form 4 |
| Sep 2, 2026 | HOLTUG LARSDirector | Sale | 236 | $62.33K | Form 4 |
| Aug 14, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 900 | $222.22K | Form 4 |
| Aug 14, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 1,100 | $270.44K | Form 4 |
| Jun 2, 2026 | SMITH SCOTT THOMASEVP & Chief Financial Officer | Buy | 100 | $21.90K | Form 4 |
| May 29, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 100 | $22.35K | Form 4 |
| May 29, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 200 | $44.46K | Form 4 |
| May 29, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 200 | $44.75K | Form 4 |
| May 29, 2026 | SMITH SCOTT THOMASEVP & Chief Financial Officer | Buy | 250 | $55.83K | Form 4 |
| May 26, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 200 | $47.87K | Form 4 |
| May 26, 2026 | BIENAIME JEAN JACQUESDirector | Buy | 200 | $47.25K | Form 4 |
| May 11, 2026 | JENSEN FLEMMING STEENSee Remarks | Sale | 19,460 | $4.64M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4